Filing Details

Accession Number:
0001388658-21-000014
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-01-21 06:03:31
Reporting Period:
2021-01-17
Accepted Time:
2021-01-21 06:03:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1388658 Irhythm Technologies Inc. IRTC Surgical & Medical Instruments & Apparatus (3841) 208149544
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1670676 A David Vort C/O Irhythm Technologies, Inc.
699 8Th St #600
San Francisco CA 94103
Evp, Sales No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-01-17 12,940 $0.00 28,542 No 4 A Direct
Common Stock Disposition 2021-01-17 6,416 $250.57 22,126 No 4 F Direct
Common Stock Acquisiton 2021-01-19 2,118 $35.25 24,244 No 4 M Direct
Common Stock Acquisiton 2021-01-19 2,882 $63.95 27,126 No 4 M Direct
Common Stock Disposition 2021-01-19 1,085 $249.95 26,041 No 4 S Direct
Common Stock Disposition 2021-01-19 1,180 $250.78 24,861 No 4 S Direct
Common Stock Disposition 2021-01-19 1,778 $251.95 23,083 No 4 S Direct
Common Stock Disposition 2021-01-19 907 $252.62 22,176 No 4 S Direct
Common Stock Disposition 2021-01-19 50 $253.57 22,126 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 F Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2021-01-19 2,118 $0.00 2,118 $35.25
Common Stock Common Stock Disposition 2021-01-19 2,882 $0.00 2,882 $63.95
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,059 2020-12-01 2027-02-16 No 4 M Direct
12,218 2019-03-01 2028-02-27 No 4 M Direct
Footnotes
  1. Represents the acquisition of shares upon the determination of the Compensation Committee of the Board of Directors of the Issuer that the performance conditions were met with respect to performance restricted stock units (PSUs) granted to the Reporting Person on June 19, 2020.
  2. Represents shares that have been withheld by the Issuer to satisfy income tax withholding and remittance obligations in connection with the issuance of shares pursuant to PSUs granted to the Reporting Person on June 19, 2020.
  3. The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2020.
  4. This transaction was executed in multiple trades at prices ranging from $249.32 to $250.19 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  5. This transaction was executed in multiple trades at prices ranging from $250.32 to $251.27 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  6. This transaction was executed in multiple trades at prices ranging from $251.335 to $252.27 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  7. This transaction was executed in multiple trades at prices ranging from $252.34 to $253.24 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  8. This option, originally granted for 25,400 shares, of which 24,341 shares have been exercised, vested as to 1/4 of the shares on March 1, 2018 and as to 1/36 of the remaining shares each month thereafter.
  9. This option, originally granted for 15,200 shares, of which 2,882 shares have been exercised, vested as to 1/4 of the shares on March 1, 2019 and as to 1/36 of the remaining shares each month thereafter.